Analyst firms · J.P. Morgan · CCCC
J.P. Morgan CCCC price target and rating history
C4 Therapeutics Inc. (CCCC) · Health Care
J.P. Morgan rates C4 Therapeutics Inc. (CCCC) Neutral with a $6 price target, as of its latest action on Jan 29, 2024. It has published 4 rating actions on CCCC since March 2022, including 1 upgrade and 2 downgrades.
- Current rating
- Neutral
- Price target
- $6
- Median target, all firms
- Too few
- Actions on CCCC
- 4
J.P. Morgan price target on CCCC
Every J.P. Morgan rating on CCCC
- Jan 29, 2024
- Feb 24, 2023
- Nov 4, 2022
- Mar 10, 2022
How other firms rate CCCC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Lake Street | Buy | $11 | Oct 28, 2026 |
| TD Cowen | Buy | Dec 2, 2025 |
Questions about J.P. Morgan and CCCC
- What is J.P. Morgan's price target for CCCC?
- J.P. Morgan's latest stated price target for C4 Therapeutics Inc. (CCCC) is $6, from its action on Jan 29, 2024.
- What is J.P. Morgan's rating on CCCC?
- J.P. Morgan rates CCCC Neutral, a neutral rating, as of Jan 29, 2024.
- When did J.P. Morgan last change its view on CCCC?
- On Jan 29, 2024, J.P. Morgan upgrades to Neutral from Underweight, price target $6.
All J.P. Morgan ratingsCCCC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.